Both APP and PATH are technology companies leveraging artificial intelligence to enhance their platforms. Which one is a ...

UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

UiPath focuses on agentic automation, boasts a large ARR base, and has high gross margins. Click here to read why PATH stock ...

UiPath (NYSE:PATH) recently launched its AI-based Medical Record Summarization Agent at the Google Cloud Next 2025 event, emphasizing efficiency and cost savings in healthcare. Despite these promising ...

Cathie Wood’s ARK ETFs have made their latest round of daily trades for Wednesday, April 9th, 2025, continuing to adjust their positions in a variety of companies across their funds. The most ...

UiPath's current-quarter and full-year outlooks came up short of estimates as the automated software maker warned of the impact of federal spending cuts and changes in the macroeconomic environment.

2025年4月7日， UiPath（PATH）披露1笔公司内部人交易情况。高管Ramani Hitesh于2025年4月3日卖出1.25万股。 2025年4月7日 高管 Ramani Hitesh 2025年4月3日 卖出 1.25万 10.19 12.73万 2025年4月3日 高管 Ramani Hitesh 2025年4月1日 卖出 2.26万 10.30 23.27万 2025年4月3日 ...

UiPath Inc. PATH stock has declined 50% over the past year against the industry's 22% rally. This analysis will explore ...

UiPath (PATH) announced at Google Cloud Next 2025 the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by ...

PATH's ARR growth decelerated for 12 consecutive quarters, with net-new ARR down 31% y/y in 4Q25, indicating poor revenue ...

UiPath's non-GAAP (adjusted) earnings of $0.26 in the quarter were up 13% from the year-ago quarter and easily outpaced Wall Street's consensus estimate of $0.20 per share. But investors mostly ...

UiPath shares rise on launch of generative AI-based UiPath Medical Record Summarization agent at Google Cloud Next 2025.